Granzyme B Expression in the Tumor Microenvironment as a Prognostic Biomarker for Patients with Triple-Negative Breast Cancer

SIMPLE SUMMARY: Triple-negative breast cancer (TNBC) is generally malignant and has a poor prognosis. New biomarkers and therapeutic strategies are therefore needed. In this study, we investigated whether granzyme B (GZMB) in the tumor microenvironment can be a biomarker of therapeutic response and...

Descripción completa

Detalles Bibliográficos
Autores principales: Mizoguchi, Kimihisa, Kawaji, Hitomi, Kai, Masaya, Morisaki, Takafumi, Hayashi, Saori, Takao, Yuka, Yamada, Mai, Shimazaki, Akiko, Osako, Tomofumi, Arima, Nobuyuki, Okido, Masayuki, Oda, Yoshinao, Nakamura, Masafumi, Kubo, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526301/
https://www.ncbi.nlm.nih.gov/pubmed/37760424
http://dx.doi.org/10.3390/cancers15184456

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526301/
https://www.ncbi.nlm.nih.gov/pubmed/37760424
http://dx.doi.org/10.3390/cancers15184456

Ejemplares similares